학술논문
Mirabegron Reduces Urinary Frequency and Improves Overactive Bladder Symptoms at 3 Months After 125 I-brachytherapy for Prostate Cancer: An Open-Labeled, Randomized, Non–Placebo-Controlled Study
Document Type
Article
Author
Source
In: Urology . (Urology, March 2022, 161:87-92)
Subject
Language
English
ISSN
15279995
00904295
00904295